Stent Thrombosis, Clinical Events, and Influence of Prolonged Clopidogrel Use After Placement of Drug-Eluting Stent: Data From an Observational Cohort Study of Drug-Eluting Versus Bare-Metal Stents
- 31 October 2008
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 1 (5), 494-503
- https://doi.org/10.1016/j.jcin.2008.06.011
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical TrialsAmerican Journal Of Medicine, 2006
- Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire?European Heart Journal, 2006
- Trading Restenosis for Thrombosis? New Questions about Drug-Eluting StentsNew England Journal of Medicine, 2006
- Patterns and outcomes of drug-eluting coronary stent use in clinical practiceAmerican Heart Journal, 2006
- Clinical Outcome Following Aleatory Implantation of Paclitaxel-Eluting or Sirolimus-Eluting Stents in Complex Coronary LesionsThe American Journal of Cardiology, 2005
- Risk of Thrombosis With the Use of Sirolimus-Eluting Stents for Percutaneous Coronary Intervention (from Registry and Clinical Trial Data)The American Journal of Cardiology, 2005
- A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stentsThe Lancet, 2004
- Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”Circulation, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003